2020
DOI: 10.3389/fimmu.2020.00513
|View full text |Cite
|
Sign up to set email alerts
|

Virus-Induced T Cell-Mediated Heterologous Immunity and Vaccine Development

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
42
0

Year Published

2020
2020
2023
2023

Publication Types

Select...
7
2
1

Relationship

2
8

Authors

Journals

citations
Cited by 38 publications
(44 citation statements)
references
References 83 publications
(84 reference statements)
0
42
0
Order By: Relevance
“…We believe that the superior protection afforded by the BA71-boosting is most probably multifactorial, contributing innate immunity and both B and T cell responses, as it has been described in different mouse models [ 38 , 39 ].…”
Section: Resultsmentioning
confidence: 99%
“…We believe that the superior protection afforded by the BA71-boosting is most probably multifactorial, contributing innate immunity and both B and T cell responses, as it has been described in different mouse models [ 38 , 39 ].…”
Section: Resultsmentioning
confidence: 99%
“…Natural killer cells (NK cells) account for 5–10% of the total number of lymphocytes and are constantly undertaking “patrol” tasks in the body. Infected host cells that lack MHC-I molecules are within the scope of NK cell attacking ( 23 , 24 ). Additionally, dendritic cells (DCs) are the main bridge between innate and adaptive immunity by antigen presentation.…”
Section: Dna Virus Infection Immune Response and Diseasesmentioning
confidence: 99%
“…These ndings suggested a T cell-mediated cross-reactivity between circulating 'common cold' coronaviruses and SARS-CoV-2. This cross-reactivity could be responsible for either enhanced protection against COVID-19 [15][16][17] or, in contrast, for antibody-dependent enhancement (ADE) of COVID-19 [18][19][20][21].…”
Section: Cd4 T Cells Of Prostate Cancer Patients Have Decreased Immunmentioning
confidence: 99%